Skip to main content
TipRanks
Go Ultimate75% OFF

Sorrento Therapeutics (SRNE) Revenue

5,213 Followers

Sorrento Therapeutics Revenue

Sorrento Therapeutics had a revenue of 15.03M in the quarter ending Jun 30, 2023, with -7.54%. This bring the company's revenue in the last twelve months to 64.27M, Increased 5.87%. In the fiscal year ending Dec 31, 2022, Sorrento Therapeutics had annual revenue of 62.84M with 18.78% growth.

Revenue (ttm)
64.27M
Revenue Growth
―
P/S Ratio
0.00
Revenue/Employee
$66,216
Employees
949
Market Cap
$165.38K

Revenue Chart

Sorrento Therapeutics Revenue - Annual

025M50M75M100M125M150M175M151.86M21.19M31.43M39.99M52.90M62.84M201720182019202020212022
Revenue History
Download to Excel
SRNE revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202262.84M9.94M18.78%
Dec 31, 202152.90M12.92M32.31%
Dec 31, 202039.99M8.55M27.21%
Dec 31, 201931.43M10.24M48.31%
Dec 31, 201821.19M-130.66M-86.04%
Dec 31, 2017151.86M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
SRNE64.27M
BDRX0.00
CNSP0.00
GRI0.00
PTIX0.00